629 related articles for article (PubMed ID: 9302301)
1. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. GG167 Influenza Study Group.
Hayden FG; Osterhaus AD; Treanor JJ; Fleming DM; Aoki FY; Nicholson KG; Bohnen AM; Hirst HM; Keene O; Wightman K
N Engl J Med; 1997 Sep; 337(13):874-80. PubMed ID: 9302301
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of the neuraminidase inhibitor zanamivir in treating influenza virus infection in adults: results from Japan. GG167 Group.
Matsumoto K; Ogawa N; Nerome K; Numazaki Y; Kawakami Y; Shirato K; Arakawa M; Kudoh S; Shimokata K; Nakajima S; Yamakido M; Kashiwagi S; Nagatake T
Antivir Ther; 1999; 4(2):61-8. PubMed ID: 10682150
[TBL] [Abstract][Full Text] [Related]
3. Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza: a randomized, double-blind, placebo-controlled European study.
Mäkelä MJ; Pauksens K; Rostila T; Fleming DM; Man CY; Keene ON; Webster A
J Infect; 2000 Jan; 40(1):42-8. PubMed ID: 10762110
[TBL] [Abstract][Full Text] [Related]
4. Inhaled zanamivir for the prevention of influenza in families. Zanamivir Family Study Group.
Hayden FG; Gubareva LV; Monto AS; Klein TC; Elliot MJ; Hammond JM; Sharp SJ; Ossi MJ;
N Engl J Med; 2000 Nov; 343(18):1282-9. PubMed ID: 11058672
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the neuraminidase inhibitor zanamivirin the treatment of influenza A and B virus infections.
Monto AS; Fleming DM; Henry D; de Groot R; Makela M; Klein T; Elliott M; Keene ON; Man CY
J Infect Dis; 1999 Aug; 180(2):254-61. PubMed ID: 10395837
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of zanamivir in patients with influenza--impact of age, severity of infections and specific risk factors.
Höffken G; Gillissen A
Med Microbiol Immunol; 2002 Dec; 191(3-4):169-73. PubMed ID: 12458354
[TBL] [Abstract][Full Text] [Related]
7. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group.
Lancet; 1998 Dec; 352(9144):1877-81. PubMed ID: 9863784
[TBL] [Abstract][Full Text] [Related]
8. Rapid antiviral effect of inhaled zanamivir in the treatment of naturally occurring influenza in otherwise healthy adults.
Boivin G; Goyette N; Hardy I; Aoki F; Wagner A; Trottier S
J Infect Dis; 2000 Apr; 181(4):1471-4. PubMed ID: 10762579
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of once daily intranasal zanamivir in preventing experimental human influenza A infection.
Calfee DP; Peng AW; Hussey EK; Lobo M; Hayden FG
Antivir Ther; 1999; 4(3):143-9. PubMed ID: 12731753
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of the neuraminidase inhibitor GG167 in experimental human influenza.
Hayden FG; Treanor JJ; Betts RF; Lobo M; Esinhart JD; Hussey EK
JAMA; 1996 Jan 24-31; 275(4):295-9. PubMed ID: 8544269
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of inhaled zanamivir in the prevention of influenza in community-dwelling, high-risk adult and adolescent subjects: a 28-day, multicenter, randomized, double-blind, placebo-controlled trial.
LaForce C; Man CY; Henderson FW; McElhaney JE; Hampel FC; Bettis R; Kudule L; Harris J; Yates P; Tisdale M; Webster A
Clin Ther; 2007 Aug; 29(8):1579-90; discussion 1577-8. PubMed ID: 17919541
[TBL] [Abstract][Full Text] [Related]
12. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
Vogel GE
Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
[TBL] [Abstract][Full Text] [Related]
13. Use of the selective oral neuraminidase inhibitor oseltamivir to prevent influenza.
Hayden FG; Atmar RL; Schilling M; Johnson C; Poretz D; Paar D; Huson L; Ward P; Mills RG
N Engl J Med; 1999 Oct; 341(18):1336-43. PubMed ID: 10536125
[TBL] [Abstract][Full Text] [Related]
14. Short-term treatment with zanamivir to prevent influenza: results of a placebo-controlled study.
Kaiser L; Henry D; Flack NP; Keene O; Hayden FG
Clin Infect Dis; 2000 Mar; 30(3):587-9. PubMed ID: 10722450
[TBL] [Abstract][Full Text] [Related]
15. Pulmonary function and airway responsiveness in mild to moderate asthmatics given repeated inhaled doses of zanamivir.
Cass LM; Gunawardena KA; Macmahon MM; Bye A
Respir Med; 2000 Feb; 94(2):166-73. PubMed ID: 10714424
[TBL] [Abstract][Full Text] [Related]
16. Zanamivir prophylaxis: an effective strategy for the prevention of influenza types A and B within households.
Monto AS; Pichichero ME; Blanckenberg SJ; Ruuskanen O; Cooper C; Fleming DM; Kerr C
J Infect Dis; 2002 Dec; 186(11):1582-8. PubMed ID: 12447733
[TBL] [Abstract][Full Text] [Related]
17. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
[TBL] [Abstract][Full Text] [Related]
18. The use of zanamivir to treat influenza A and B infection after allogeneic stem cell transplantation.
Johny AA; Clark A; Price N; Carrington D; Oakhill A; Marks DI
Bone Marrow Transplant; 2002 Jan; 29(2):113-5. PubMed ID: 11850704
[TBL] [Abstract][Full Text] [Related]
19. Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
Phillips TG
J Fam Pract; 2003 Oct; 52(10):747-8. PubMed ID: 14529590
[No Abstract] [Full Text] [Related]
20. Zanamivir: from drug design to the clinic.
Elliott M
Philos Trans R Soc Lond B Biol Sci; 2001 Dec; 356(1416):1885-93. PubMed ID: 11779388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
